Dobbin Malcolm, Liew David Fl
Aust Prescr. 2020 Oct;43(5):164-167. doi: 10.18773/austprescr.2020.050. Epub 2020 Oct 1.
Misuse of opioid analgesics and other psychoactive medicines is a serious and increasing problem in Australia. Measures are being taken to try and prevent this progressing to a public health crisis like the opioid overdose epidemic seen in the USA One measure is real-time prescription monitoring. This provides real-time information about the patient’s supply of psychoactive medicines which have a high risk of being misused Having identified a patient at risk, many factors may delay appropriate management or result in the patient being discharged from care. These factors include subconscious negative stereotyping, a focus on preventing ‘doctor shoppers’ diverting psychoactive medicines, and a fear of sanction by regulators The Medical Board of Australia provides guidance about good practice. Patients should be treated with respect, free from bias and discrimination, and without prejudicing care because of the belief that their behaviour has contributed to their problems
在澳大利亚,阿片类镇痛药和其他精神活性药物的滥用是一个严重且日益严重的问题。目前正在采取措施,试图防止这一问题演变成像美国所出现的阿片类药物过量流行那样的公共卫生危机。其中一项措施是实时处方监测。这能提供有关患者精神活性药物供应的实时信息,这些药物被滥用的风险很高。在确定有风险的患者后,许多因素可能会延迟适当的管理,或者导致患者出院。这些因素包括潜意识的负面刻板印象、专注于防止“多科就诊者”转移精神活性药物,以及对监管机构制裁的恐惧。澳大利亚医学委员会提供了关于良好做法的指导。患者应受到尊重,不受偏见和歧视,并且不会因为认为其行为导致了自身问题而影响治疗。